CCEL
Price:
$6.7516
Market Cap:
$54.43M
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company marke...[Read more]
Industry
Medical - Care Facilities
IPO Date
1994-04-04
Stock Exchange
NASDAQ
Ticker
CCEL
According to Cryo-Cell International, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.08. This represents a change of -139.24% compared to the average of 15.50 of the last 4 quarters.
The mean historical PE Ratio of Cryo-Cell International, Inc. over the last ten years is 8.76. The current -6.08 PE Ratio has changed -7042.01% with respect to the historical average. Over the past ten years (40 quarters), CCEL's PE Ratio was at its highest in in the May 2019 quarter at 248.03. The PE Ratio was at its lowest in in the February 2016 quarter at -60.63.
Average
8.76
Median
14.14
Minimum
-56.64
Maximum
48.35
Discovering the peaks and valleys of Cryo-Cell International, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 223.91%
Maximum Annual PE Ratio = 48.35
Minimum Annual Increase = -772.35%
Minimum Annual PE Ratio = -56.64
Year | PE Ratio | Change |
---|---|---|
2023 | -4.69 | -135.11% |
2022 | 13.35 | -72.39% |
2021 | 48.35 | 223.91% |
2020 | 14.93 | -39.25% |
2019 | 24.57 | -143.38% |
2018 | -56.64 | -359.90% |
2017 | 21.79 | -194.19% |
2016 | -23.13 | -772.35% |
2015 | 3.44 | -92.46% |
2014 | 45.61 | -92.97% |
The current PE Ratio of Cryo-Cell International, Inc. (CCEL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
19.00
5-year avg
19.30
10-year avg
8.76
Cryo-Cell International, Inc.’s PE Ratio is less than National HealthCare Corporation (21.62), greater than InnovAge Holding Corp. (-27.39), less than The Pennant Group, Inc. (49.65), less than Encompass Health Corporation (22.92), less than Aesthetic Medical International Holdings Group Limited (-2.87), greater than AirSculpt Technologies, Inc. (-60.62), greater than Aveanna Healthcare Holdings Inc. (-8.33), less than The Oncology Institute, Inc. (-0.36), greater than Brookdale Senior Living Inc. (-7.36), less than Surgery Partners, Inc. (543.82), less than Select Medical Holdings Corporation (15.55), less than The Ensign Group, Inc. (37.39), less than Pediatrix Medical Group, Inc. (-3.77), less than P3 Health Partners Inc. (-0.90), greater than Sonida Senior Living, Inc. (-22.12), greater than Acadia Healthcare Company, Inc. (-1369.41), less than DocGo Inc. (12.28), less than Concord Medical Services Holdings Limited (-0.94),
Company | PE Ratio | Market cap |
---|---|---|
21.62 | $1.99B | |
-27.39 | $844.49M | |
49.65 | $961.78M | |
22.92 | $9.22B | |
-2.87 | $15.93M | |
-60.62 | $207.33M | |
-8.33 | $1.05B | |
-0.36 | $22.64M | |
-7.36 | $1.33B | |
543.82 | $3.84B | |
15.55 | $4.39B | |
37.39 | $8.51B | |
-3.77 | $905.03M | |
-0.90 | $164.55M | |
-22.12 | $499.12M | |
-1369.41 | $7.10B | |
12.28 | $371.41M | |
-0.94 | $26.65M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cryo-Cell International, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cryo-Cell International, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cryo-Cell International, Inc.'s PE Ratio?
How is the PE Ratio calculated for Cryo-Cell International, Inc. (CCEL)?
What is the highest PE Ratio for Cryo-Cell International, Inc. (CCEL)?
What is the 3-year average PE Ratio for Cryo-Cell International, Inc. (CCEL)?
What is the 5-year average PE Ratio for Cryo-Cell International, Inc. (CCEL)?
How does the current PE Ratio for Cryo-Cell International, Inc. (CCEL) compare to its historical average?